0001953017-22-000001.txt : 20221206 0001953017-22-000001.hdr.sgml : 20221206 20221206110810 ACCESSION NUMBER: 0001953017-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20221206 DATE AS OF CHANGE: 20221206 EFFECTIVENESS DATE: 20221206 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Lusaris Therapeutics, Inc. CENTRAL INDEX KEY: 0001953017 IRS NUMBER: 872970305 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-466642 FILM NUMBER: 221446968 BUSINESS ADDRESS: STREET 1: 200 BERKELEY STREET, 18TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-778-2500 MAIL ADDRESS: STREET 1: 200 BERKELEY STREET, 18TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 D 1 primary_doc.xml X0708 D LIVE 0001953017 Lusaris Therapeutics, Inc. 630 Davis Drive, Suite 220 Morrisville NC NORTH CAROLINA 27560 617-778-2500 DELAWARE None None Corporation true 2021 Edward Monaghan C/O LUSARIS THERAPEUTICS, INC. 630 Davis Drive, Suite 220 Morrisville NC NORTH CAROLINA 27560 Executive Officer Director Promoter Andrew Levin C/O LUSARIS THERAPEUTICS, INC. 630 Davis Drive, Suite 220 Morrisville NC NORTH CAROLINA 27560 Executive Officer Director Daniel Grau C/O LUSARIS THERAPEUTICS, INC. 630 Davis Drive, Suite 220 Morrisville NC NORTH CAROLINA 27560 Director Catherine Riesen C/O LUSARIS THERAPEUTICS, INC. 630 Davis Drive, Suite 220 Morrisville NC NORTH CAROLINA 27560 Executive Officer Neil Buckley C/O LUSARIS THERAPEUTICS, INC. 630 Davis Drive, Suite 220 Morrisville NC NORTH CAROLINA 27560 Executive Officer Ramin Farzaneh-Far C/O LUSARIS THERAPEUTICS, INC. 630 Davis Drive, Suite 220 Morrisville NC NORTH CAROLINA 27560 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2022-10-13 false true false 0 60156164 60156164 0 false 9 0 0 0 false Lusaris Therapeutics, Inc. Andrew Levin Andrew Levin Interim Chief Executive Officer 2022-12-06